Breast Reconstruction Market | Europe | 2018-2024 | MedCore

  • Year: 2018
  • Scope: 2014-2024
  • Region: Europe
  • Pages: 604
  • Type: MedCore

The total breast reconstruction market is expected to show moderate growth in upcoming years, fueled by the continuing success of biologics, especially LifeCell’s Strattice™, which has been showing substantial growth since its introduction to the European market. The outstanding clinical reviews and patient satisfaction garnered by biologic matrices will allow Strattice™ to continue to be a popular choice when it comes to breast reconstruction. Conversely, declining reimbursement will place downward pressure on the ASP of mesh used in breast reconstruction.

Breast reconstruction is the replacement of breast tissue that has been lost during mastectomy, trauma or due to congenital defects, and the creation of a new breast form. This report includes breast reconstructions that follow mastectomy. The procedure is done by placing an implant under the skin and chest muscle, or by transplanting tissue from another part of the body to the chest area, or by a combination of these techniques. The aim is to match as closely as possible the remaining natural breast, in order to achieve desired symmetry.

Segments Covered in This Market

  • Biologic Breast Reconstruction Market
  • Synthetic Breast Reconstruction Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the many companies in the Europe Breast Reconstruction market, Lifecell was the leader, followed by PFM Medical and Baxter. LifeCell dominated in the biologic market with its Strattice™ and ARTIA™ reconstructive tissue matrices, which are both ADMs derived from porcine dermis. It is processed and preserved in a phosphate-buffered aqueous solution containing matrix stabilizers. PFM Medical offers the only non-resorbable synthetic mesh product specifically approved for breast reconstruction. Baxter offers VERITAS® collagen matrix, a xenograft derived from bovine pericardium. VERITAS® was first introduced into Europe for abdominal wall repair, but has found more success in the breast reconstruction indication.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Europe Market Report Suite for Soft Tissue Reinforcement and Regeneration – MedSuite

Learn More about these product types

FREE Sample Report

The "Breast Reconstruction Market " includes analysis on the following companies currently active in this market: Lifecell PFM Medical Baxter Novus Scientific *Not all companies may be currently active in every segment. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology